Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Apolipoprotein E and renal disease.

Evagelos Liberopoulos1, Kostas Siamopoulos, Moses Elisaf

  • 1Department of Internal Medicine, University of Ioannina, Ioannina, Greece.

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|January 30, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The long-term effect of a lung-ultrasound intervention on the risk for death, heart failure and myocardial infarction in dialysis patients.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2023
Same author

Long-term risk, clinical management, and healthcare resource utilization of stable patients with coronary artery disease and post-myocardial infarction in Greece - TIGREECE study.

Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese·2023
Same author

The Effect of Commonly Used Fixed-Dose Single Pill Combinations of Renin-Angiotensin-System Blockers and Calcium Channel Blockers on HOMA-IR Index in Hypertensive Patients with Impaired Fasting Glucose: a 12-Week Randomized Open-Label Prospective Study.

Maedica·2022
Same author

Moderately elevated lipoprotein (a) levels are associated with an earlier need for percutaneous coronary intervention in recurrent cardiovascular disease.

Experimental and therapeutic medicine·2022
Same author

A randomized multicenter trial on a lung ultrasound-guided treatment strategy in patients on chronic hemodialysis with high cardiovascular risk.

Kidney international·2021
Same author

Lipoprotein(a): A Concealed Precursor of Increased Cardiovascular Risk? A Real-World Regional Lipid Clinic Experience.

Archives of medical research·2020
Same journal

Approach to Hyperkalemia: The Role of Diet and Pharmacological Therapies.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same journal

High Protein Diets: What to Tell Our Patients.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same journal

Progressive Kidney Dysfunction and Ocular Clues: A Quiz.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same journal

Influence of Lactate Dehydrogenase on the Measurement of Blood Bicarbonate.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same journal

Urinary CXCL9 and CXCL10, Interstitial Inflammation and Disease Activity Over Time in Acute Interstitial Nephritis.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same journal

Hemophagocytic Lymphohistiocytosis and Fibroblast Growth Factor 23 (FGF23)-Induced Hypophosphatemia.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
See all related articles

Apolipoprotein E (ApoE) influences kidney disease, affecting lipid levels in uremic patients and potentially impacting diabetic nephropathy and glomerulopathies. Certain ApoE gene mutations are linked to lipoprotein glomerulopathy.

Area of Science:

  • Nephrology
  • Cardiovascular Science
  • Genetics

Background:

  • Apolipoprotein E (ApoE) is crucial in lipoprotein metabolism and has diverse biological functions.
  • ApoE polymorphisms are known to affect lipid profiles, atherosclerosis, and neurodegenerative diseases.
  • Emerging evidence highlights ApoE's significant role in renal disease pathogenesis and progression.

Purpose of the Study:

  • To elucidate the multifaceted role of Apolipoprotein E in various renal diseases.
  • To examine the impact of ApoE polymorphisms on lipid levels and cardiovascular risk in uremic patients.
  • To investigate the association between ApoE gene mutations and lipoprotein glomerulopathy.

Main Methods:

  • Review of existing literature on ApoE, lipid metabolism, and renal diseases.

Related Experiment Videos

  • Analysis of studies investigating ApoE polymorphisms in uremic and diabetic populations.
  • Examination of genetic data linking ApoE mutations to lipoprotein glomerulopathy.

    • Main Results:

    • ApoE polymorphisms significantly influence plasma lipid levels in uremic patients.
    • ApoE status may modulate the risk of cardiovascular disease and diabetic nephropathy.
    • ApoE plays a role in the severity of certain glomerulopathies and kidney microenvironment functions.
    • Specific ApoE gene mutations are identified as causative factors in lipoprotein glomerulopathy.

    Conclusions:

    • Apolipoprotein E is a key factor in the development and progression of diverse renal diseases.
    • Understanding ApoE's role is critical for managing cardiovascular complications in kidney disease patients.
    • Further research into ApoE genetics may offer novel therapeutic targets for kidney disorders like lipoprotein glomerulopathy.